"FDA" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonFDA reverses course, agrees to review Moderna’s flu vaccine - statnews.com
FDA updates peanut butter recall in 40 states, including NJ, Pa. - 6abc Philadelphia
- FDA updates peanut butter recall in 40 states, including NJ, Pa. 6abc Philadelphia
- FDA Announces Peanut Butter Recall in 40 States—Products May Contain Pieces of Plastic Health: Trusted and Empathetic Health and Wellness Information
- Check your pantry: Peanut butter recalled in 40 states USA Today
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addi...
FDA investigating Salmonella outbreak connected to moringa powder - CBS News
FDA investigating Salmonella outbreak connected to moringa powder CBS News
FDA Approves FILKRI™ (filgrastim-laha), Accord BioPharma's Biosimilar to NEUPOGEN® (filgrastim) -...
FDA Approves FILKRI™ (filgrastim-laha), Accord BioPharma's Biosimilar to NEUPOGEN® (filgrastim) PR Newswire
Top Republican eyeing FDA overhaul - The Hill
Top Republican eyeing FDA overhaul The Hill
FDA issues new guidance on antibiotic use in food-producing animals - CIDRAP
FDA issues new guidance on antibiotic use in food-producing animals CIDRAP
Compass’ Psychedelic Shows Durability ‘In-Spades’ as Path to FDA Clears - BioSpace
Compass’ Psychedelic Shows Durability ‘In-Spades’ as Path to FDA Clears BioSpace
Kennedy says FDA "will act on" ultra-processed foods petition, but indicates no new rules - Axios
Kennedy says FDA "will act on" ultra-processed foods petition, but indicates no new rules Axios
Human "biology was never intended to handle" ultraprocessed foods, former FDA head David Kessler ...
Chlorine Dioxide, Raw Camel Milk: The FDA No Longer Warns Against These and Other Ineffective Aut...
Novartis heads to FDA with Rhapsido after ph. 3 win in untapped chronic hives subtype - Fierce Ph...
Novartis heads to FDA with Rhapsido after ph. 3 win in untapped chronic hives subtype Fierce Pharma
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine - The New York Times
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine The New York Times
FDA reverses course and will review Moderna’s mRNA flu shot, company says - CNN
FDA reverses course and will review Moderna’s mRNA flu shot, company says CNN
Reversing Course, FDA Will Now Review Moderna's Influenza Vaccine - Contagion Live
Reversing Course, FDA Will Now Review Moderna's Influenza Vaccine Contagion Live
Something is very wrong at the FDA - The Hill
Something is very wrong at the FDA The Hill
FDA reverses course, will review Moderna's mRNA flu vaccine - NBC News
FDA reverses course, will review Moderna's mRNA flu vaccine NBC News
FDA Approves New Treatment for Patients with Locally Advanced Pancreatic Cancer: What You Need to...
FDA Approves New Treatment for Patients with Locally Advanced Pancreatic Cancer: What You Need to Know Pancreatic Cancer Action Network
Why the FDA is cracking down on compound GLP-1 drugs for weight loss - Scientific American
Why the FDA is cracking down on compound GLP-1 drugs for weight loss Scientific American
US FDA reverses course, will review Moderna's revised flu vaccine application - Reuters
US FDA reverses course, will review Moderna's revised flu vaccine application Reuters
FDA Clears ARCUS Editor for Duchenne Hot-spot - CRISPR Medicine News
FDA Clears ARCUS Editor for Duchenne Hot-spot CRISPR Medicine News
Cassidy proposes FDA overhaul - Punchbowl News
Cassidy proposes FDA overhaul Punchbowl News
Complex Innovative Trial Design Meeting Program - fda.gov
FDA will now review flu vaccine it had rejected - Axios
FDA Decides to Review Moderna’s Flu Shot in Surprise Reversal - Bloomberg
FDA Decides to Review Moderna’s Flu Shot in Surprise Reversal Bloomberg
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate - Scripps News
FDA reverses course, will review Moderna’s mRNA flu vaccine candidate Scripps News
FDA updates peanut butter recall that includes product from Houston wholesaler - Houston Chronicle
FDA updates peanut butter recall that includes product from Houston wholesaler Houston Chronicle
FDA Reverses Course and Will Now Review Moderna’s Flu Shot - The Wall Street Journal
FDA Reverses Course and Will Now Review Moderna’s Flu Shot The Wall Street Journal
The FDA’s Moderna pirouette is one more sign of chaos at the agency - statnews.com
The FDA’s Moderna pirouette is one more sign of chaos at the agency statnews.com
FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal - Scientific American
FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal Scientific American
FDA accepts filing for Moderna flu vaccine after swift rethink - Fierce Biotech
FDA accepts filing for Moderna flu vaccine after swift rethink Fierce Biotech
Johns Hopkins Fellows visit FDA, learn impact of new technology on public health regulation - Lib...
Johns Hopkins Fellows visit FDA, learn impact of new technology on public health regulation Liberty University
J&J’s Rybrevant Faspro gains FDA approval for new dosing in NSCLC - Pharmaceutical Technology
J&J’s Rybrevant Faspro gains FDA approval for new dosing in NSCLC Pharmaceutical Technology
Berkshire reduces Apple stake, FDA to review Moderna vaccine - Yahoo Finance
Berkshire reduces Apple stake, FDA to review Moderna vaccine Yahoo Finance
FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision - BioSpace
FDA Reverses Course on Moderna’s mRNA Flu Shot Application, Promising August Decision BioSpace
Moderna says the FDA will consider its new flu shot after resolving a public dispute - Norwalk Hour
Moderna says the FDA will consider its new flu shot after resolving a public dispute Norwalk Hour
FDA Expands Indication for Pitolisant to Treat Cataplexy in Pediatric Narcolepsy - NeurologyLive
FDA Expands Indication for Pitolisant to Treat Cataplexy in Pediatric Narcolepsy NeurologyLive
FDA issues massive peanut butter recall across 40 states, including WA - MyNorthwest.com
FDA issues massive peanut butter recall across 40 states, including WA MyNorthwest.com
Digital Health Center of Excellence - fda.gov
FDA Initiating Review of Moderna’s Seasonal Flu Vaccine Following Revised Regulatory Approach - P...
FDA Initiating Review of Moderna’s Seasonal Flu Vaccine Following Revised Regulatory Approach Pharmaceutical Executive
FDA agrees to review Moderna's mRNA-based flu vaccine - FirstWord Pharma
FDA agrees to review Moderna's mRNA-based flu vaccine FirstWord Pharma
Portal Diabetes’ insulin pump receives FDA breakthrough device designation - Medical Device Network
Portal Diabetes’ insulin pump receives FDA breakthrough device designation Medical Device Network
Chairman of Senate health committee floats an overhaul of FDA in new report - Baltimore Sun
Chairman of Senate health committee floats an overhaul of FDA in new report Baltimore Sun
Over 20,000 Peanut Butter Products Recalled Due to Contamination Concerns, FDA Reports - Prevention
Over 20,000 Peanut Butter Products Recalled Due to Contamination Concerns, FDA Reports Prevention
Moderna Stock Jumps as FDA Initiates Review of Flu Vaccine - Barron's
Moderna Stock Jumps as FDA Initiates Review of Flu Vaccine Barron's
FDA’s Proposed Self-GRAS Rule May Take Ingredients Off the Table - Bloomberg Law News
FDA’s Proposed Self-GRAS Rule May Take Ingredients Off the Table Bloomberg Law News
Trump-era FDA clears path for Moderna flu vaccine review after regulatory standoff - Fox Business
Trump-era FDA clears path for Moderna flu vaccine review after regulatory standoff Fox Business
Cassidy unveils FDA modernization plan - The Hill
Moderna strikes compromise with FDA to advance flu vaccine for 2026 approval - The Business Journals
Moderna strikes compromise with FDA to advance flu vaccine for 2026 approval The Business Journals
FDA reverses course and will review Moderna’s mRNA-based flu shot - The Washington Post
FDA reverses course and will review Moderna’s mRNA-based flu shot The Washington Post
FDA Changes Drug Trial Guidance: Experts Take Sides - Medscape
FDA Changes Drug Trial Guidance: Experts Take Sides Medscape
FDA relents and will review Moderna's flu shot - pharmaphorum
FDA relents and will review Moderna's flu shot pharmaphorum
Moderna Jumps After FDA Reverses Decision On Flu Vaccine - Investor's Business Daily
Moderna Jumps After FDA Reverses Decision On Flu Vaccine Investor's Business Daily
Experts argue recent FDA expert panels may violate FACA requirements - Regulatory Affairs Profess...
Experts argue recent FDA expert panels may violate FACA requirements Regulatory Affairs Professionals Society | RAPS
Store brand peanut butter recall extended by FDA - KOAT
If you have this kitchen staple in your pantry, the FDA says to toss it immediately - AL.com
If you have this kitchen staple in your pantry, the FDA says to toss it immediately AL.com
Moderna stock rises after FDA agrees to review seasonal flu vaccine - Investing.com
Moderna stock rises after FDA agrees to review seasonal flu vaccine Investing.com
FDA to initiate review of Moderna seasonal flu vaccine submission - The Pharma Letter
FDA to initiate review of Moderna seasonal flu vaccine submission The Pharma Letter
Pharmalittle: We're reading about an FDA reversal on a Moderna vaccine, the U.K. life sciences se...
Pharmalittle: We're reading about an FDA reversal on a Moderna vaccine, the U.K. life sciences sector, and more statnews.com
FDA Accepts NDA for Iberdomide Combination in R/R Multiple Myeloma - CancerNetwork
FDA Accepts NDA for Iberdomide Combination in R/R Multiple Myeloma CancerNetwork
Bill Cassidy Releases His Own Plan to Overhaul the FDA - NOTUS — News of the United States
Bill Cassidy Releases His Own Plan to Overhaul the FDA NOTUS — News of the United States
Spruce Biosciences Gains After Positive FDA Type B Meetings On TA-ERT - Nasdaq
Spruce Biosciences Gains After Positive FDA Type B Meetings On TA-ERT Nasdaq
Criminal Investigations - fda.gov
Criminal Investigations fda.gov
Flour Recall Update as FDA Sets Risk Level - Newsweek
FDA reverses decision not to review Moderna’s new flu vaccine - New York Post
FDA reverses decision not to review Moderna’s new flu vaccine New York Post
FDA starts review of BMS's 'celmod' for multiple myeloma - pharmaphorum
FDA starts review of BMS's 'celmod' for multiple myeloma pharmaphorum
Outbreak Investigation of Salmonella: Moringa Leaf Powder (January 2026) - fda.gov
Outbreak Investigation of Salmonella: Moringa Leaf Powder (January 2026) fda.gov
Moderna says the FDA will consider its new flu shot after resolving a public dispute - The Tri-Ci...
Moderna says the FDA will consider its new flu shot after resolving a public dispute The Tri-City Record
FDA expands age indication for Staar Surgical EVO ICL - MassDevice
FDA expands age indication for Staar Surgical EVO ICL MassDevice
FDA warns contract manufacturer for GMP violations, clinical investigator for not following trial...
FDA warns contract manufacturer for GMP violations, clinical investigator for not following trial protocol Regulatory Affairs Professionals Society | RAPS
FDA Approves Once-Monthly Dosing Schedule for Amivantamab and Hyaluronidase-lpuj - The ASCO Post
FDA Approves Once-Monthly Dosing Schedule for Amivantamab and Hyaluronidase-lpuj The ASCO Post
FDA Approves Monthly First-Line Amivantamab and Hyaluronidase Dosing for EGFR-Mutated, Advanced N...
FDA reverses course, will review Moderna flu shot - MS NOW
FDA Approval Granted for Commercial Manufacturing at Rezon Bio's Warsaw-Duchnice Facility - Busin...
FDA Approval Granted for Commercial Manufacturing at Rezon Bio's Warsaw-Duchnice Facility Business Wire
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addi...
FDA chief Marty Makary says 'everything should be over-the-counter' unless drug is unsafe or addictive-CNBC TradingView
The Cassidy Report on the FDA - Marginal REVOLUTION
The Cassidy Report on the FDA Marginal REVOLUTION
Food Update | GRAS‑ping the Moment: FDA GRAS Reform Steps Into the Spotlight - Akin
Food Update | GRAS‑ping the Moment: FDA GRAS Reform Steps Into the Spotlight Akin
Moderna Stock Pops as FDA Application Moves Forward - Schaeffer's Investment Research
Moderna Stock Pops as FDA Application Moves Forward Schaeffer's Investment Research
Moderna says the FDA will consider its new flu shot after resolving a public dispute - ClickOnDet...
Moderna says the FDA will consider its new flu shot after resolving a public dispute ClickOnDetroit | WDIV Local 4
Nurse Stabbed to Death; FDA Reverses Controversial Decision; Brain Scan Kickbacks - MedPage Today
Nurse Stabbed to Death; FDA Reverses Controversial Decision; Brain Scan Kickbacks MedPage Today
U.S. FDA changes course and agrees to review Moderna's mRNA flu vaccine application - CBC
U.S. FDA changes course and agrees to review Moderna's mRNA flu vaccine application CBC
Moderna gains as FDA accepts flu shot for review (MRNA:NASDAQ) - Seeking Alpha
Moderna gains as FDA accepts flu shot for review (MRNA:NASDAQ) Seeking Alpha
FDA Approval Sought for Iberdomide Plus Daratumumab/Dexamethasone in R/R Multiple Myeloma - OncLive
FDA Approval Sought for Iberdomide Plus Daratumumab/Dexamethasone in R/R Multiple Myeloma OncLive
New Jersey included in nationwide peanut butter recall. What to know - Bergen Record
New Jersey included in nationwide peanut butter recall. What to know Bergen Record
Why Practical FDA Submissions Training Makes the Difference - AdvaMed® - Advanced Medical Technol...
Why Practical FDA Submissions Training Makes the Difference AdvaMed® - Advanced Medical Technology Association®
The FDA’s Crackdown on The Food Additives Making Us Sick - FOX News Radio
The FDA’s Crackdown on The Food Additives Making Us Sick FOX News Radio
NY among 40 states impacted by FDA recall of peanut butter products - Newsday
NY among 40 states impacted by FDA recall of peanut butter products Newsday
RYBREVANT FASPRO receives U.S. FDA Breakthrough Therapy Designation for patients with advanced he...
RYBREVANT FASPRO receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer Investing News Network
FDA approves pitolisant (WAKIX) for cataplexy in pediatric narcolepsy - Contemporary Pediatrics
FDA approves pitolisant (WAKIX) for cataplexy in pediatric narcolepsy Contemporary Pediatrics
FDA pushes to close regulatory loophole for ultraprocessed foods - NewsNation
FDA pushes to close regulatory loophole for ultraprocessed foods NewsNation
RFK Jr. Elevates Top FDA Human Foods Official to HHS Management Team - Food Safety Magazine
RFK Jr. Elevates Top FDA Human Foods Official to HHS Management Team Food Safety Magazine
Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment ...
How Will The Kennedy FDA Impact DTC Television Creativity - DTC Perspectives
How Will The Kennedy FDA Impact DTC Television Creativity DTC Perspectives
FDA approves ferric maltol for iron deficiency in children aged 10 years and older - Contemporary...
FDA approves ferric maltol for iron deficiency in children aged 10 years and older Contemporary Pediatrics
Phase 2 Study of CYC-126 for Treatment Resistant Depression Receives FDA Feedback, Will Proceed -...
Phase 2 Study of CYC-126 for Treatment Resistant Depression Receives FDA Feedback, Will Proceed Psychiatric Times
FDA Accepts NDA for Iberdomide-Based Regimen in Multiple Myeloma - Targeted Oncology
FDA Accepts NDA for Iberdomide-Based Regimen in Multiple Myeloma Targeted Oncology
Breaking news: The FDA reversed course and agreed to review Moderna’s application for the first m...
FDA Rare Disease Innovation Hub - fda.gov
FDA Rare Disease Innovation Hub fda.gov
FDA Approves Filkri, Filgrastim Biosimilar Referencing Neupogen for Cancer Treatment-Related Indi...
FDA Approves Filkri, Filgrastim Biosimilar Referencing Neupogen for Cancer Treatment-Related Indications Pharmacy Times
Moderna says the FDA will consider its new flu shot after resolving a public dispute - WKMG
Moderna says the FDA will consider its new flu shot after resolving a public dispute WKMG
FDA Approves Once-Monthly Dosing Schedule for Amivantamab and Hyaluronidase-lpuj in EGFR-Mutated ...
FDA Approves Once-Monthly Dosing Schedule for Amivantamab and Hyaluronidase-lpuj in EGFR-Mutated NSCLC Pharmacy Times